Vaniprevir (MK-7009) is an orally active HCV NS3/4A protease inhibitor with a Ki of 0.05 nM against genotype 1, 0.9 nM against genotype 2, 0.07 nM against genotype 1a, 0.06 nM against genotype 1b, 1 nM against genotype 2a, and 1.4 nM against genotype 2b. Vaniprevir exhibits high selectivity for human proteases, ion channels, receptors and enzymes. Vaniprevir can be used in research related to chronic hepatitis C and HCV infection[1][2][3][4].
Molecular Weight:
757.94
Purity:
99.60
CAS Number:
[923590-37-8]
Formula:
C38H55N5O9S
Target:
HCV,HCV Protease
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
